Literature DB >> 18286247

[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].

Peter Mikosch1.   

Abstract

Amiodarone is a frequently used antiarrhythmic drug with a high antiarrhythmic potency. However, beside its antiarrhythmic effects Amiodarone also reveals a variety of adverse effects and drug-related complications. The affected organs include the eyes, skin, lungs, nervous system, liver, gastrointestinal tract and the thyroid. The thyroid is one of the most frequently affected organs by Amiodarone. An altered hormone equilibrium always occurs and has to be distinguished from Amiodarone induced hyperthyroidism and hypothyroidism. The differentiation of these states frequently causes problems and may even be a diagnostic and therapeutic challenge in certain cases. The article gives an overview on the interactions between Amiodarone and the thyroid, the diagnostic and therapeutic options and management strategies of patient on Amiodarone therapy in the view of thyroid function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286247     DOI: 10.1007/s10354-007-0475-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  36 in total

1.  Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory lodization of common salt.

Authors:  Martin Heinisch; Gerhild Kumnig; Doris Asböck; Peter Mikosch; Hans-Júrgen Gallowitsch; Ewald Kresnik; Iris Gomez; Oliver Unterweger; Peter Lind
Journal:  Thyroid       Date:  2002-09       Impact factor: 6.568

Review 2.  Iodine supplementation in Austria: methods and results.

Authors:  P Lind; G Kumnig; M Heinisch; I Igerc; P Mikosch; H J Gallowitsch; E Kresnik; I Gomez; O Unterweger; H Aigner
Journal:  Thyroid       Date:  2002-10       Impact factor: 6.568

3.  Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.

Authors:  G Iervasi; A Clerico; R Bonini; C Manfredi; S Berti; M Ravani; C Palmieri; A Carpi; A Biagini; I J Chopra
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

4.  Monitoring the use of amiodarone: compliance with guidelines.

Authors:  C Burgess; A Blaikie; T Ingham; G Robinson; S Narasimhan
Journal:  Intern Med J       Date:  2006-05       Impact factor: 2.048

5.  [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].

Authors:  J S Hermida; G Jarry; E Tcheng; V Moullart; S Arlot; J L Rey; C Schvartz
Journal:  Arch Mal Coeur Vaiss       Date:  2004-03

Review 6.  Amiodarone: guidelines for use and monitoring.

Authors:  Lyle A Siddoway
Journal:  Am Fam Physician       Date:  2003-12-01       Impact factor: 3.292

7.  Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.

Authors:  Omer Alyan; Kemal Arda; Ozcan Ozdemir; Berat Acu; Mustafa Soylu; Deniz Demirkan
Journal:  Med Sci Monit       Date:  2003-09

8.  [Iodine supply and struma in Austria].

Authors:  G Galvan
Journal:  Acta Med Austriaca       Date:  1993

9.  Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; L Bartalena; M Lenziardi; C Ceccarelli; G Bambini; M Safran; L E Braverman; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1987-02       Impact factor: 3.478

10.  Drug-induced thyrotoxicosis: the surgical option.

Authors:  Mordechai Lorberboym; Pinhas Schachter
Journal:  Isr Med Assoc J       Date:  2007-02       Impact factor: 0.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.